Ceredex Value Advisors LLC Buys 13,915 Shares of Humana Inc. $HUM

Key Points

• Ceredex Value Advisors raised its Humana stake by 19.4%, buying 13,915 shares to hold 85,565 shares worth about $22.26 million (roughly 0.07% of the company), while institutional investors own 92.38% of Humana.
• Humana beat Q results (EPS -$3.96 vs. -$4.01 consensus; revenue $32.64B vs. $32.08B) and set FY2026 EPS guidance of 9.00, and it declared a quarterly dividend of $0.885 ($3.54 annual, ~2.0% yield).

Ceredex Value Advisors LLC lifted its position in Humana Inc. (NYSE:HUM - Free Report) by 19.4% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 85,565 shares of the insurance provider's stock after buying an additional 13,915 shares during the quarter. Ceredex Value Advisors LLC owned about 0.07% of Humana worth $22,261,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. Unison Advisors LLC increased its stake in shares of Humana by 0.4% during the 3rd quarter. Unison Advisors LLC now owns 10,137 shares of the insurance provider's stock worth $2,646,000 after purchasing an additional 37 shares during the last quarter. Insigneo Advisory Services LLC increased its position in Humana by 3.0% during the third quarter. Insigneo Advisory Services LLC now owns 1,484 shares of the insurance provider's stock worth $386,000 after buying an additional 43 shares during the last quarter. Synovus Financial Corp raised its stake in Humana by 2.0% in the third quarter. Synovus Financial Corp now owns 2,278 shares of the insurance provider's stock valued at $593,000 after buying an additional 45 shares during the period. Private Wealth Management Group LLC lifted its position in shares of Humana by 47.5% in the third quarter. Private Wealth Management Group LLC now owns 149 shares of the insurance provider's stock valued at $39,000 after buying an additional 48 shares during the last quarter. Finally, Ossiam boosted its stake in shares of Humana by 1.6% during the 2nd quarter. Ossiam now owns 4,375 shares of the insurance provider's stock worth $1,070,000 after acquiring an additional 71 shares during the period. Institutional investors and hedge funds own 92.38% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on HUM shares. UBS Group restated a "neutral" rating on shares of Humana in a research note on Wednesday, February 25th. Wolfe Research increased their price objective on shares of Humana from $300.00 to $325.00 and gave the company an "outperform" rating in a research report on Thursday, January 8th. Morgan Stanley set a $146.00 target price on shares of Humana in a report on Thursday, February 12th. Truist Financial lowered their price target on shares of Humana from $285.00 to $200.00 and set a "hold" rating on the stock in a report on Tuesday, February 17th. Finally, Oppenheimer set a $250.00 price objective on Humana in a report on Thursday, February 12th. Seven analysts have rated the stock with a Buy rating, sixteen have assigned a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat.com, Humana currently has an average rating of "Hold" and an average price target of $225.48.

Humana Trading Down 0.5%

HUM stock opened at $178.25 on Tuesday. Humana Inc. has a 52 week low of $169.61 and a 52 week high of $315.35. The company has a market capitalization of $21.50 billion, a PE ratio of 18.15, a price-to-earnings-growth ratio of 1.93 and a beta of 0.44. The company's 50-day simple moving average is $220.15 and its 200 day simple moving average is $251.18. The company has a debt-to-equity ratio of 0.70, a quick ratio of 2.00 and a current ratio of 2.00.

Humana (NYSE:HUM - Get Free Report) last issued its quarterly earnings data on Wednesday, February 11th. The insurance provider reported ($3.96) earnings per share for the quarter, topping the consensus estimate of ($4.01) by $0.05. The business had revenue of $32.64 billion during the quarter, compared to analysts' expectations of $32.08 billion. Humana had a net margin of 0.92% and a return on equity of 11.43%. The business's revenue was up 11.3% on a year-over-year basis. During the same quarter in the previous year, the company earned ($2.16) EPS. Humana has set its FY 2026 guidance at 9.000-9.000 EPS. As a group, sell-side analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 24th. Stockholders of record on Friday, March 27th will be given a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 2.0%. The ex-dividend date is Friday, March 27th. Humana's payout ratio is presently 36.05%.

Insider Activity

In related news, insider Sanjay K. Shetty purchased 810 shares of Humana stock in a transaction that occurred on Monday, February 23rd. The shares were acquired at an average price of $185.21 per share, with a total value of $150,020.10. Following the completion of the transaction, the insider directly owned 11,657 shares of the company's stock, valued at $2,158,992.97. This represents a 7.47% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.37% of the company's stock.

About Humana

Humana Inc NYSE: HUM is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana's products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.